Biocryst Pharmaceuticals (BCRX) EPS (Basic) (QoQ) (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.10 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 110.34% |
| Mar 31, 2026 | -354.38% |
| Dec 31, 2025 | 1,808.49% |
| Sep 30, 2025 | 152.87% |
| Jun 30, 2025 | 15,742.31% |
| Mar 31, 2025 | 100.12% |
| Dec 31, 2024 | -91.14% |
| Sep 30, 2024 | -10.47% |
| Jun 30, 2024 | 64.24% |
| Mar 31, 2024 | 46.54% |
| Dec 31, 2023 | -68.50% |
| Sep 30, 2023 | 52.14% |
| Jun 30, 2023 | -40.78% |
| Mar 31, 2023 | 26.48% |
| Dec 31, 2022 | -68.50% |
| Sep 30, 2022 | 27.98% |
| Jun 30, 2022 | 20.97% |
| Mar 31, 2022 | -304.28% |
| Dec 31, 2021 | 69.77% |
| Sep 30, 2021 | -35.38% |